June #48 : Volunteers Wanted - by Lark Lands

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Afterimage

Beyond Condoms: Introduction

Beyond Condoms

Beyond Condoms: Life After Latex

Ouch! Stop the Pain

Catching Up With . . . Jim Howley

Drag King

Queen of Hearts

S.O.S.

To the Editor

Hypodermic Hysteria

Streethearts

POZarazzi: Party Poop

Frogs Out of Hot Water

Clip 'n' Save

Swing Vote

Think Stink

"WeHo" Heave Ho

Little Rocked

Say What

Obits

Patriot Games

Policy Permutations

Ghost Reader

Show & Tell

Rescue 3-8-7

Dose Encounters

Nurse a Grudge

A Bum Rap

Where There’s Smoke...

Feelin' No Pain

Tranny Time

Where to Find It

Get Over It

Volunteers Wanted

Not Your Typical Tearjerker

Displace Dysplasia

Prevention Extension

Posterboy Always Rings Twice

Sense and Sinsemilla

POZ Picks

Aunt Evelyn's Letters



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

June 1999

Volunteers Wanted

by Lark Lands

HIV positives needed to test a drug that could destroy your hips, thin your bones, mess up your toenails, keep your penis limp (men) and run riot with your red blood cells (women). Warning: HAART-takers need not apply. Why? You’re already enrolled. Lest you thought lipodystrophy was the worst curse of the protease age, here are five new studies that hint at more freaky side effects.

Results from a study of 260 HIV positive Spaniards on protease inhibitors (PIs) showed that 14 (5 percent) were unable to achieve or maintain an erection and had decreased sex drive and/or problems ejaculating, despite normal testosterone levels and no other apparent impotence-causing factors. In a Danish study, four of 10 women with normal menstrual function pre-HAART developed anemia associated with heavy bleeding when given ritonavir (Norvir); in three, the problems resolved when a different PI was substituted. Researchers in Argentina report major loss of bone mineral density—today’s thinning bones may be tomorrow’s osteoporosis—in 17 HAART-taking men. Georgetown University scientists have found avascular necrosis—the death of hip tissue—in eight patients on PIs, a small percentage but a big jump compared to the pre-HAART era. And confirming what the community has long suspected, a French study shows that Crixivan (indinavir)—alone of the PIs and NNRTIs—is strongly associated with ingrown toenails.  




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dambitious
    Gone
    New York


    usuallyhappy
    Palm Springs
    California


    TaintedloveDC
    Washington
    DC


    josebos
    Boston strong
    Massachusetts
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.